OTHER GROUP COMPANIES
market

Past year’s performance of BSE Healthcare and Pharma Funds

BSE benchmark index-Sensex gave approximate return of 25% in past one year by rising 5738 points (from 23154 points on February 26, 2016 to 28892 points on February 23, 2017).

February 26, 2017 8:30 IST | India Infoline News Service
BSE benchmark index-Sensex gave approximate return of 25% in past one year by rising 5738 points (from 23154 points on February 26, 2016 to 28892 points on February 23, 2017).

Whereas, BSE Healthcare index showed a nominal growth of 1.10% in the same period.
 
A look at some leading Pharma funds suggests that they have been underperformers in terms of one year gains.

SBI Pharma Fund just gave a return of 1.74%, which is still better than BSE Healthcare index and holds the top position among its peers.

On the other hand, Tata India Pharma & Healthcare Fund – Regular Plan has turned out to be the worst performer with negative returns of 8.27% to its investors in the past one year.

Fund name 1 year return (%) Net Assets (Cr)
SBI Pharma Fund 1.74 1008
Reliance Pharma Fund 0.76 1456
UTI Pharma & Healthcare Fund 0.39 312
Tata India Pharma & Healthcare Fund – Regular Plan (8.27) 80



 
 
 
 

OPEN A DEMAT ACCOUNT & Get FREE Benefits worth 10,000

OPEN A DEMAT ACCOUNT & Get
FREE Benefits worth 10,000

STOCK VIEW

PRESTIGE (NSE)

The average score for Prestige Estates Projects Limited stands at 4 against 6, three months back.

Prestige Estates Projects Limited is engaged in the business of real estate development. The Company’s principal products/services include Development and construction

FEATURED ARTICLE

BLOGS

Open ZERO Brokerage Demat Account

  • 0

    Delivery Brokerage for Lifetime

  • 20

    Per order for Intraday, F&O, Currency & Commodity